| Market Capitalization (Millions $) |
56 |
| Shares
Outstanding (Millions) |
54 |
| Employees |
124 |
| Revenues (TTM) (Millions $) |
36 |
| Net Income (TTM) (Millions $) |
-19 |
| Cash Flow (TTM) (Millions $) |
2 |
| Capital Exp. (TTM) (Millions $) |
0 |
Cytosorbents Corporation
Cytosorbents Corporation is a medical device company that specializes in blood purification technology. The company's flagship product, Cytosorb, is designed to remove harmful substances from the bloodstream, such as cytokines, toxins, and excessive fluids, in critically ill patients. The technology behind Cytosorb involves the use of highly porous polymer beads that adsorb these substances, helping to alleviate inflammation and organ dysfunction. Cytosorbents Corporation aims to improve patient outcomes and reduce the impact of severe conditions like sepsis, acute respiratory distress syndrome, and other life-threatening conditions.
Company Address: 305 College Road East Princeton, 8540 NJ
Company Phone Number: 329-8885 Stock Exchange / Ticker: NASDAQ CTSO
|
2.21% 
92.79 %